Skip to main content

Animations

MJFF Publications

4461 - 4470 of 8823 Results
Title
Year
  • Year
  • 2017
  • 2022
  • 2014
  • 2015
  • 2015
  • 2023
  • 2020
  • 2018
  • 2015
  • 2019
  • Summary Details
    OPEN
    Title: Heritability of hippocampal subfield volumes using a twin and non-twin siblings design
    Journal Name: Human Brain Mapping
    Publisher: Wiley
    Publication Date:
    Open Access(OA) Status: OPEN
    License:
    DOI - Digital Object Identifier: 10.1002/hbm.23654
    Citation Count: 29
  • Summary Details
    RESTRICTED
    Title: CRISPR/Cas9‐Based Functional Genomics in Human Induced Pluripotent Stem Cell–Derived Models: Can “the Stars Align” for Neurodegenerative Diseases?
    Journal Name: Movement Disorders
    Publisher: Wiley
    Publication Date:
    Open Access(OA) Status: RESTRICTED
    License:
    DOI - Digital Object Identifier: 10.1002/mds.28998
    Citation Count: 1
  • Summary Details
    RESTRICTED
    Title: The BioFIND Study (Fox Investigation For New Discovery Of Biomarkers In Parkinson’s Disease): Design And Methodology (P4.043)
    Journal Name: Neurology
    Publisher: Ovid Technologies (Wolters Kluwer Health)
    Publication Date:
    Open Access(OA) Status: RESTRICTED
    License:
    DOI - Digital Object Identifier: 10.1212/wnl.82.10_supplement.p4.043
    Citation Count: 5
  • Summary Details
    OPEN
    Title: Fidelity of frequency and phase entrainment of circuit-level spike activity during DBS
    Journal Name: Journal of Neurophysiology
    Publisher: American Physiological Society
    Publication Date:
    Open Access(OA) Status: OPEN
    License:
    DOI - Digital Object Identifier: 10.1152/jn.00259.2015
    Citation Count: 47
  • Summary Details
    RESTRICTED
    Title: Thalamic deep brain stimulation for drug-induced tremor
    Journal Name: Parkinsonism & Related Disorders
    Publisher: Elsevier BV
    Publication Date:
    Open Access(OA) Status: RESTRICTED
    License:
    DOI - Digital Object Identifier: 10.1016/j.parkreldis.2015.08.033
    Citation Count: 7
  • Summary Details
    RESTRICTED
    Title: Corneal confocal microscopy demonstrates varying degrees of neurodegeneration in atypical parkinsonian disorders
    Journal Name: Parkinsonism & Related Disorders
    Publisher: Elsevier BV
    Publication Date:
    Open Access(OA) Status: RESTRICTED
    License:
    DOI - Digital Object Identifier: 10.1016/j.parkreldis.2023.105899
    Citation Count: 5
  • Summary Details
    OPEN
    Title: An application of generalized matrix learning vector quantization in neuroimaging
    Journal Name: Computer Methods and Programs in Biomedicine
    Publisher: Elsevier BV
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by
    DOI - Digital Object Identifier: 10.1016/j.cmpb.2020.105708
    Citation Count: 17
  • Summary Details
    OPEN
    Title: Inflammasome inhibition prevents α-synuclein pathology and dopaminergic neurodegeneration in mice
    Journal Name: Science Translational Medicine
    Publisher: American Association for the Advancement of Science (AAAS)
    Publication Date:
    Open Access(OA) Status: OPEN
    License:
    DOI - Digital Object Identifier: 10.1126/scitranslmed.aah4066
    Citation Count: 719
  • Summary Details
    OPEN
    Title: A lipid switch unlocks Parkinson’s disease-associated ATP13A2
    Journal Name: Proceedings of the National Academy of Sciences
    Publisher: Proceedings of the National Academy of Sciences
    Publication Date:
    Open Access(OA) Status: OPEN
    License:
    DOI - Digital Object Identifier: 10.1073/pnas.1508220112
    Citation Count: 91
  • Summary Details
    OPEN
    Title: The kainate receptor antagonist UBP310 but not single deletion of GluK1, GluK2, or GluK3 subunits, inhibits MPTP-induced degeneration in the mouse midbrain
    Journal Name: Experimental Neurology
    Publisher: Elsevier BV
    Publication Date:
    Open Access(OA) Status: OPEN
    License:
    DOI - Digital Object Identifier: 10.1016/j.expneurol.2019.113062
    Citation Count: 14
We use cookies to ensure that you get the best experience. By continuing to use this website, you indicate that you have read our Terms of Service and Privacy Policy.